Bio Farma Indonesia Leads Global Vaccine Manufacturers as Host of the 26th DCVMN AGM in Bali
BALI, Indonesia, Oct. 31, 2025 /PRNewswire/ -- Bali, October 29, 2025, Indonesia, through Bio Farma, is hosting the 26th Annual General Meeting (AGM) of the Developing Countries Vaccine Manufacturers Network (DCVMN) in Bali on October 29–31, 2025. The forum brings together vaccine manufacturers, global health institutions, and partners under the theme Advancing innovation and building a resilient vaccine ecosystem...
Alpha Fusion Initiates Company-Sponsored Clinical Trial of Alpha-Emitting Radiopharmaceutical af-001 in Patients with Differentiated Thyroid Cancer
– Aiming to establish af-001 as a new therapeutic option for radioactive iodine (RAI)-naïve patients with differentiated thyroid cancer – TOKYO, Oct. 31, 2025 /PRNewswire/ -- Alpha Fusion Inc. (Headquarters: Chiyoda-ku, Tokyo; CEO: Sunao Fujioka; hereinafter "Alpha Fusion") today announced the initiation of a company-sponsored Phase I clinical trial (jRCT2031250472) of the alpha-emitting...
Elevaris Medical Devices Names New Chief Engineering and Operations Officer
BOSTON, Oct. 31, 2025 /PRNewswire/ -- Elevaris Medical Devices, a Contract Development and Manufacturing Organization for industry-leading multi-national healthcare companies, announced the appointment of its new Chief Engineering and Operations Officer, Salvador Montes. "I have deep respect for the legacy Elevaris is leveraging and immense belief in our potential...
Kexing Biopharm Showcases Global Strategy and Partnership Opportunities at CPHI Frankfurt 2025
FRANKFURT, Germany, Oct. 31, 2025 /PRNewswire/ -- From October 28th to 30th, Kexing Biopharm participated in CPHI Frankfurt 2025, one of the world's most influential pharmaceutical exhibitions, presenting its key product portfolio and international commercialization solutions to partners from global markets. During the event, Kexing Biopharm's international business team held productive meetings with industry representatives from multiple countries. Discussions...
JW Therapeutics and Regeneron Expand Strategic Collaboration Agreement to Advance TCR-T Cell Therapy Development and Maximize Global Platform Potential
SHANGHAI, Oct. 31, 2025 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced the execution of an Amendment to its strategic collaboration agreement with Regeneron Pharmaceuticals, Inc. ("Regeneron"), a leading global biotechnology company. This amendment not only signifies a major upgrade in long-term partnership between the...
Xinhua Silk Road: Chinese biz leaders hold talks to explore cultural inheritance, innovation
BEIJING, Oct. 31, 2025 /PRNewswire/ -- On Tuesday, an in-depth talk between board chairmen of Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd. (Pien Tze Huang) and Kweichow Moutai Group highlighted joint effort to promote inheritance and innovation of traditional Chinese culture. After discussing related topics such as inheritance of time-honored Chinese brands, Lin Zhihui, board chairman of Pien Tze Huang...
Catalent Debuts New Corporate Brand, Elevating Customer Service Excellence by “Championing the Missions that Matter™”
TAMPA, Fla., Oct. 31, 2025 /PRNewswire/ -- Catalent, Inc., a leading global contract development and manufacturing organization, today unveiled its new corporate brand, marking a strategic evolution that underscores the company's commitment to delivering unparalleled customer service and its focus on "championing the missions that matter." The new approach reflects Catalent's dedication to helping its pharmaceutical, biotech and consumer...
Singapore Court Confirms GNC’s Rights to Assume Former GNC Store Leases from LAC, Setting the Stage for Continued Growth in Singapore
Ruling reduces market confusion and reinforces GNC's science‑backed leadership; company accelerates partnership with Watsons to deliver best‑in‑class wellness solutions for consumers PITTSBURGH, Oct. 31, 2025 /PRNewswire/ -- GNC, the global leader in science‑backed health and wellness, welcomed the Singapore International Commercial Court's ("SICC") decision to uphold an arbitration award requiring ONI Global Pte....
IMG Wins Two 2025 Travel Weekly Magellan Awards
INDIANAPOLIS, Oct. 30, 2025 /PRNewswire/ -- IMG (International Medical Group) has been recognized with two Travel Weekly Magellan Awards for excellence in travel insurance. IMG earned Gold in the Travel Insurance Product category for its renowned iTravelInsured Choice plan and was awarded Silver in the Travel Insurance Customer Service category for its commitment...
NovaBridge Subsidiary Visara Assigns Its Exclusive License to Everest Medicines for VIS-101 in Greater China and Certain Other Asian Countries
NovaBridge subsidiary Visara assigned its exclusive license to Everest Medicines to accelerate the development of potential best-in-class therapy for wet AMD, VIS-101, leveraging Everest Medicines' strong clinical and commercialization expertise in Greater China and other Asian markets NovaBridge also named Mr. Ian Woo, President and Chief Financial Officer of Everest Medicines, to its Board of Directors, bringing substantial...
